Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
DYN · NASDAQ · Pharmaceutical Preparations
$15.50−0.53 (−3.31%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Dyne Therapeutics (DYN) · oqro.io/stocks/DYN · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
Wellington Management Group LLP now owns 5.7% of DYN as a passive investorSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
CEO sold ~$93K of DYN shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
CFO sold ~$33K of DYN shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Officer sold ~$44K of DYN shares in the open marketSourceInsider trade · Traded Nov 13, 2026 · Filed Nov 16, 2026
Officer sold ~$3.9K of DYN shares in the open marketSourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 13, 2026
Soros Fund Management disclosed a new position in DYN for Q3 2026SourcePlanned sale · Planned for Nov 13, 2026 · Notice filed Nov 13, 2026
Officer filed to sell about $93K of DYN stockSourcePlanned sale · Planned for Nov 13, 2026 · Notice filed Nov 13, 2026
Officer filed to sell about $44K of DYN stockSourceInsider trade · Traded Oct 2, 2026 · Filed Oct 7, 2026
Director purchased ~$40K of DYN shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC disclosed a reduced position in DYN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbimed Advisors LLC disclosed an increased position in DYN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Deep Track Capital, LP disclosed a reduced position in DYN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Samlyn Capital, LLC disclosed a reduced position in DYN for Q2 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 29, 2026
Perceptive Advisors LLC disclosed an increased position in DYN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbimed Advisors LLC disclosed an increased position in DYN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Orbis Allan Gray Ltd disclosed an increased position in DYN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Samlyn Capital, LLC disclosed an increased position in DYN for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Samlyn Capital, LLC disclosed a new position in DYN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbis Allan Gray Ltd disclosed a new position in DYN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Perceptive Advisors LLC disclosed an increased position in DYN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
RTW Investments, LP no longer reported DYN for Q4 2025Fund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deep Track Capital, LP disclosed a new position in DYN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Paradigm Biocapital Advisors LP disclosed a new position in DYN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in DYN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Orbimed Advisors LLC disclosed an increased position in DYN for Q3 2025Insider trade · Traded Sep 5, 2025 · Filed Sep 9, 2025
CEO sold ~$35K of DYN shares in the open marketSourceInsider trade · Traded Sep 4, 2025 · Filed Sep 8, 2025
Officer sold ~$47K of DYN shares in the open marketSourceInsider trade · Traded Sep 4, 2025 · Filed Sep 8, 2025
Officer sold ~$12K of DYN shares in the open marketSourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
Officer sold ~$12K of DYN shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deep Track Capital, LP no longer reported DYN for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Perceptive Advisors LLC disclosed a reduced position in DYN for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Frazier Life Sciences Management, L.P. disclosed an increased position in DYN for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Orbimed Advisors LLC disclosed an increased position in DYN for Q2 2025Insider trade · Traded Jul 14, 2025 · Filed Jul 15, 2025
CEO purchased ~$911K of DYN shares in the open marketSourceInsider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
CEO sold ~$54K of DYN shares in the open marketSourceInsider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
Officer sold ~$18K of DYN shares in the open marketSourceInsider trade · Traded Jun 5, 2025 · Filed Jun 6, 2025
Officer sold ~$1.9K of DYN shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Frazier Life Sciences Management, L.P. disclosed a new position in DYN for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Ra Capital Management, L.P. disclosed an increased position in DYN for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
RTW Investments, LP disclosed a reduced position in DYN for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Orbimed Advisors LLC disclosed a reduced position in DYN for Q1 2025Insider trade · Traded Mar 11, 2025 · Filed Mar 13, 2025
Officer sold ~$25K of DYN shares in the open marketSourceInsider trade · Traded Mar 11, 2025 · Filed Mar 13, 2025
Officer sold ~$15K of DYN shares in the open marketSourceInsider trade · Traded Mar 13, 2025 · Filed Mar 13, 2025
Officer sold ~$1.7K of DYN shares in the open marketSourceInsider trade · Traded Mar 5, 2025 · Filed Mar 7, 2025
CEO sold ~$48K of DYN shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 25, 2025
Officer sold ~$36K of DYN shares in the open marketSourceInsider trade · Traded Feb 18, 2025 · Filed Feb 18, 2025
Officer sold ~$35K of DYN shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Deep Track Capital, LP disclosed a reduced position in DYN for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
RTW Investments, LP disclosed a reduced position in DYN for Q4 2024SourceInsider trade · Traded Dec 11, 2024 · Filed Dec 12, 2024
Officer sold ~$66K of DYN shares in the open marketSourceInsider trade · Traded Dec 11, 2024 · Filed Dec 12, 2024
Officer sold ~$41K of DYN shares in the open marketSourceInsider trade · Traded Dec 6, 2024 · Filed Dec 10, 2024
Director sold ~$2.98M of DYN shares in the open marketSourceInsider trade · Traded Dec 9, 2024 · Filed Dec 10, 2024
Director sold ~$1M of DYN shares in the open marketSourceInsider trade · Traded Nov 18, 2024 · Filed Nov 19, 2024
Director sold ~$474K of DYN shares in the open marketSourceInsider trade · Traded Nov 14, 2024 · Filed Nov 18, 2024
Director sold ~$19K of DYN shares in the open marketSourceInsider trade · Traded Nov 14, 2024 · Filed Nov 18, 2024
Director sold ~$4.1K of DYN shares in the open marketSourceInsider trade · Traded Nov 14, 2024 · Filed Nov 18, 2024
Director sold ~$132 of DYN shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 22, 2024
Director sold ~$472K of DYN shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Orbis Allan Gray Ltd disclosed an increased position in DYN for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Siren, L.L.C. disclosed a reduced position in DYN for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Deep Track Capital, LP disclosed a reduced position in DYN for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Siren, L.L.C. disclosed a reduced position in DYN for Q1 2026SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Paradigm Biocapital Advisors LP no longer reported DYN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Orbimed Advisors LLC disclosed a reduced position in DYN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Siren, L.L.C. disclosed a reduced position in DYN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Frazier Life Sciences Management, L.P. disclosed an increased position in DYN for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Deep Track Capital, LP disclosed an increased position in DYN for Q4 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Ra Capital Management, L.P. no longer reported DYN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
RTW Investments, LP disclosed an increased position in DYN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Perceptive Advisors LLC disclosed a reduced position in DYN for Q3 2025SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 13, 2025
Siren, L.L.C. disclosed a reduced position in DYN for Q3 2025SourceInsider trade · Traded Sep 5, 2025 · Filed Sep 8, 2025
Officer sold ~$1.9K of DYN shares in the open marketSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 13, 2025
Siren, L.L.C. disclosed an increased position in DYN for Q2 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed Aug 6, 2025
Perceptive Advisors LLC disclosed an increased position in DYN for Q1 2025SourceInsider trade · Traded Mar 5, 2025 · Filed Mar 7, 2025
Officer sold ~$16K of DYN shares in the open marketSourceInsider trade · Traded Mar 5, 2025 · Filed Mar 7, 2025
Officer sold ~$13K of DYN shares in the open marketSourceInsider trade · Traded Mar 5, 2025 · Filed Mar 7, 2025
Officer sold ~$11K of DYN shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Orbimed Advisors LLC disclosed an increased position in DYN for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Siren, L.L.C. disclosed an increased position in DYN for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Perceptive Advisors LLC disclosed a reduced position in DYN for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Avoro Capital Advisors LLC no longer reported DYN for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Holocene Advisors, LP disclosed an increased position in DYN for Q4 2024SourceInsider trade · Traded Dec 4, 2024 · Filed Dec 6, 2024
Director sold ~$3.97M of DYN shares in the open marketSourceInsider trade · Traded Dec 5, 2024 · Filed Dec 6, 2024
Director sold ~$111K of DYN shares in the open marketSourceInsider trade · Traded Dec 2, 2024 · Filed Dec 4, 2024
Director sold ~$2.37M of DYN shares in the open marketSourceInsider trade · Traded Dec 3, 2024 · Filed Dec 4, 2024
Director sold ~$864K of DYN shares in the open marketSourceInsider trade · Traded Dec 2, 2024 · Filed Dec 4, 2024
Director sold ~$37K of DYN shares in the open marketSourceInsider trade · Traded Nov 14, 2024 · Filed Nov 18, 2024
Director sold ~$2.4K of DYN shares in the open marketSourceInsider trade · Traded Nov 18, 2024 · Filed Nov 18, 2024
Officer sold ~$81K of DYN shares in the open marketSourceInsider trade · Traded Nov 18, 2024 · Filed Nov 18, 2024
Officer sold ~$77K of DYN shares in the open marketSourceInsider trade · Traded Nov 13, 2024 · Filed Nov 15, 2024
Director sold ~$381K of DYN shares in the open marketSourceInsider trade · Traded Nov 14, 2024 · Filed Nov 15, 2024
Director sold ~$293K of DYN shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deep Track Capital, LP disclosed a reduced position in DYN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
RTW Investments, LP disclosed an increased position in DYN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Perceptive Advisors LLC disclosed a new position in DYN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Ra Capital Management, L.P. disclosed an increased position in DYN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Deerfield Management Company, L.P. disclosed a new position in DYN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Avoro Capital Advisors LLC disclosed an increased position in DYN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Eventide Asset Management, LLC disclosed a reduced position in DYN for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Holocene Advisors, LP disclosed a reduced position in DYN for Q3 2024Source